3 ms·
> Practically, it is not experiment. The U.S. NIH says otherwise, e.g. here is one of the ongoing clinical studies, which continues through March 2023, https:/
by walterbell 4y ago
> Practically, it is not experiment.
The U.S. NIH says otherwise, e.g. here is one of the ongoing clinical studies, which continues through March 2023, https://clinicaltrials.gov/ct2/show/NCT04848584 https://clinicaltrials.gov/ct2/show/NCT04848584
Study Type: Observational
Official Title: Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California
Actual Study Start Date: May 15, 2021
Estimated Primary Completion Date: March 31, 2023
Estimated Study Completion Date: March 31, 2023
> covid-19 vaccines
WHO lists 11 vaccines and 4 types, each with different mechanisms of action, effectiveness and safety, https://covid19.trackvaccines.org/agency/who/ https://covid19.trackvaccines.org/agency/who/
Protein subunit
RNA
Non Replicating Viral Vector
Inactivated Virus
- watwut 4y agoThere being ongoing related studies does not mean the whole vaccination thing is experiment. The level of manipulativeness and appeals to emotions rather then logic are super high higher. Also there are way more then just 11 vaccines all in all.
- walterbell 4y ago> ongoing related studies does not mean the whole vaccination thing is experiment It means that the outcome of vaccine studies which complete in 2023, e.g. medium-term adverse effects, identification of specific risk pools, mitigations for adverse effects, will primarily benefit those who receive treatment after the studies complete in 2023. Any beneficial information from a study completing in 2023 would self-evidently not be available in 2021 and 2022, i.e. science would have yielded new scientific knowledge. Participating in an ongoing scientific procedure with partial data is a risk-benefit decision, but that does not make it any less of an experiment, when there is ongoing, parallel research, clinical trials and scientists working diligently to answer open questions.